e-SPACE Cardio-Renal-Metabolic 2024

Published: 29 March 2024

  • Views:

    Views Icon 211

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

KDIGO and Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology were delighted to announce the return of e-SPACE Cardio-Renal-Metabolic (CRM) 2024.

 

A thoughtfully curated programme supported the exploration of how leading experts, in cardiology, nephrology and diabetology, treat the interrelated diseases.

 

This event once again brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, alongside KDIGO's mission to improve the care and outcomes of patients with kidney disease worldwide through the development and implementation of global clinical practice guidelines, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.

 

Related sessions to e-SPACE Cardio-Renal-Metabolic 2024:

e-SPACE Cardio-Renal-Metabolic 2024 would like to thank the following sponsors:

Learning Objectives

  • Review the burden of diabetes, kidney disease and heart failure including morbidity, excess mortality and reduced quality of life affecting individuals around the world
  • Describe the complexity and interlink between the three conditions
  • Discuss existing guidelines and best approaches for screening patients
  • Review evidence-based management strategies for diabetes, cardiovascular disease, heart failure, kidney disease and obesity including SLGT2i, GLP-1RA, new non-steroidal mineralocorticoid receptor antagonists and other emerging therapies
  • Foster cross-collaboration between other cardiorenal / metabolic specialists and primary care physicians and allied health care professionals in order to improve patients outcomes

Target Audience

  • Cardiologists
  • Nephrologists
  • Diabetologists
  • General Practitioners (GPs)
  • HF Specialists
  • Nurses, Pharmacists, and other Allied Healthcare Professionals

More from this programme

Part 1

Day One

6 sessions
Plenary Session 1 – Multidisciplinary implementation strategies Watch now
Keynote Session – KDIGO guideline updates 2024 Watch now
Plenary Session 2 – Guideline directed therapy for CRM disease: the evidence base Watch now
Plenary Session 3 – Managing the patients with CRM: who gets what, when and why? Watch now
Plenary Session 4 – Weight homeostasis management in CRM disease (Organised with support from Charité Friends & Sponsors Trust) Watch now
Plenary Session 5 – CRM disease: epidemiology and pathophysiology Watch now

Part 2

Day Two

6 sessions
Plenary Session 6 – Anaemia and iron deficiency Watch now
Practical implementation of non-steroidal mineralocorticoid receptor antagonists to reduce cardiorenal risk Watch now
Plenary Session 7 – Clinical presentations and treatment across the patient journey: focus on CKD and CVD Watch now
Plenary Session 8 – Early intervention and intensive management Watch now
Effects of GLP- 1RA on kidney outcomes in CKD and T2D Watch now
Plenary Session 9 – Precision medicine in CRM Watch now

Faculty Biographies

Scott Isaacs

Scott Isaacs

Endocrinologist

Dr Scott Isaacs is an Endocrinologist at Atlanta Endocrine Associates, Georgia, US.

His interests are in obesity medicine, fatty liver disease, thyroid disorders, cardiometabolic disease, dyslipidemia, diabetes and general endocrinology.

View full profile
Peter Rossing

Peter Rossing

Clinical Professor

Prof Peter Rossing is a Clinical Professor at University of Copenhagen, Copenhagen, DK.

His interests include complications in diabetes with focus on renal and cardiovascular complications.

He has been involved in several intervention studies in patients with overt diabetic nephropathy aiming at improving the prognosis.

Prof Rossing is past president of the Danish Endocrine Society, and of the European Diabetic Nephropathy Study group and chairman of the Danish National Diabetes Registry.

View full profile
Muthiah Vaduganathan

Muthiah Vaduganathan

Consultant Cardiologist

Dr Vaduganathan is a Cardiologist and clinical trialist at Brigham and Women’s Hospital and Harvard Medical School. He is co-director of the Center for Cardiometabolic Implementation Science at Brigham and Women’s Hospital. He is a co-chair of a Heart Failure Collaboratory committee focused on improving future clinical trials in heart failure, and serves on the planning committee of the Global CardioVascular Clinical Trialists Forum. He is a Section Editor of the Fellows-in-Training / Early Career section of JACC, Associate Editor of JACC Heart Failure, and serves on the editorial board of the European Journal of Heart Failure. His research focuses on drug development, clinical trials, and implementation of cardio-renal-metabolic therapies, and he has authored or co-authored more than 500 peer-reviewed publications. He participates on study leadership and on committees of ongoing advanced-phase trials in cardiometabolic medicine and heart failure.…

View full profile
Stefan Anker

Stefan Anker

Professor of Cardiology

Prof Stefan Anker is professor of (Tissue) Homeostasis in Cardiology & Metabolism at Charité Berlin, Germany, since June 2017. Prodigious researcher who has authored more than 1,000 articles. He has also won several prizes, including the 2018 Copernicus Prize of German DFG & Polish FNP. In October 2020, he was awarded a Doctor honoris causa of Medical University Wroclaw, Poland.

Prof Anker has been serving on the board of the Heart Failure Association (HFA) of the ESC since 2006 and was HFA President from 2012 to 2014. He currently chairs the HFA committee on regulatory affairs. He is founding Editor-in-Chief of the first open-access heart failure journal, ESC Heart Failure. Prof. Anker has served on several ESC Guideline task forces.

Prof Anker is the founding president of the International Society on Sarcopenia, Cachexia and Wasting Disorders (SCWD) and founding Editor-in-Chief of the Journal of Cachexia, Sarcopenia and…

View full profile
Javed Butler

Javed Butler

Professor of Medicine

Dr Javed Butler is President, Baylor Scott and White Research Institute, Senior Vice President for the Baylor Scott and White Health and Professor of Medicine at the University of Mississippi, US. He is board certified in cardiovascular medicine and advanced heart failure and transplant medicine. His research interests focus on clinical trials in patients with heart failure.

He serves on several national committees for the American College of Cardiology, American Heart Association, National Institutes of Health, and the Heart Failure Society of America. He is the recipient of the Simon Dack Award by the American College of Cardiology as well as the Time, Feeling, and Focus Award by the American Heart Association.

Prof Butler has authored more than 900 peer-reviewed publications. He serves on the editorial board of several peer reviewed cardiovascular journals and has been cited numerous times in America’s Best Doctors list.

 

View full profile

Comments

You must be to comment. If you are not registered, you can register here.